scholarly article | Q13442814 |
P6179 | Dimensions Publication ID | 1015916140 |
P356 | DOI | 10.1007/S00520-004-0684-4 |
P8608 | Fatcat ID | release_5vcjs7brh5cchf3hvuzhz27eqq |
P698 | PubMed publication ID | 15480820 |
P2093 | author name string | Jean-Jacques Body | |
Dominique A Lossignol | |||
Myriam Obiols-Portis | |||
P2860 | cites work | Evidence of a role for NMDA receptors in pain perception | Q28253098 |
Breakthrough pain: definition, prevalence and characteristics | Q33435886 | ||
Ketamine--its pharmacology and therapeutic uses. | Q34272894 | ||
Intraventricular morphine administration for control of chronic cancer pain | Q39237699 | ||
Low-dose ketamine in the management of opioid nonresponsive terminal cancer pain | Q39440047 | ||
When all else fails: stepwise multiple solutions for a complex cancer pain syndrome | Q39441928 | ||
Validation of World Health Organization Guidelines for cancer pain relief: a 10-year prospective study | Q39471539 | ||
Pitfalls in the use of opiates in treatment of cancer pain | Q39491522 | ||
Comparison of ketamine and pethidine in experimental and postoperative pain | Q41350025 | ||
Analgesic and cognitive effects of intravenous ketamine-alfentanil combinations versus either drug alone after intradermal capsaicin in normal subjects | Q42541818 | ||
The treatment of cancer pain | Q43074092 | ||
The combination of NMDA antagonism and morphine produces profound antinociception in the rat dorsal horn | Q43499579 | ||
Studies on the spinal interaction of morphine and the NMDA antagonist MK-801 on the hyperesthesia observed in a rat model of sciatic mononeuropathy | Q46159568 | ||
Effects of intravenous ketamine, alfentanil, or placebo on pain, pinprick hyperalgesia, and allodynia produced by intradermal capsaicin in human subjects. | Q51590011 | ||
Response of chronic neuropathic pain syndromes to ketamine: a preliminary study. | Q51644389 | ||
The Edmonton staging system for cancer pain: preliminary report. | Q52266786 | ||
Intrathecal administration of high-dose morphine solutions decreases the pH of cerebrospinal fluid | Q71981382 | ||
NMDA receptor antagonists: interactions with opioids | Q73133273 | ||
P433 | issue | 3 | |
P304 | page(s) | 188-193 | |
P577 | publication date | 2004-10-06 | |
P1433 | published in | Supportive Care in Cancer | Q15766919 |
P1476 | title | Successful use of ketamine for intractable cancer pain | |
P478 | volume | 13 |